Selective photosensitizer delivery into plasma membrane for effective photodynamic therapy

Journal of Controlled Release

Volumn 191, Issue , 2014, Pages 98-104

  Kim, Jiyoung ^a   Santos, Olavo Amorim ^b   Park, Ji Ho ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

Cancer; Drug delivery; Membrane fusogenic liposome; Photodynamic therapy; Photosensitizer

Indexed keywords

CELL DEATH; CELL MEMBRANES; CELLS; CYTOLOGY; DRUG DELIVERY; LIPOSOMES; MOLECULAR BIOLOGY; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS;

CANCER; FUSOGENIC LIPOSOMES; INTRACELLULAR COMPARTMENTS; LIPOSOMAL DELIVERY SYSTEM; LIPOSOMAL FORMULATION; REACTIVE OXYGEN SPECIES; SUBCELLULAR COMPARTMENTS; SUBCELLULAR LOCALIZATIONS;

MEMBRANES;

NANOCARRIER; PHOTOSENSITIZING AGENT; PHTHALOCYANINE ZINC; REACTIVE OXYGEN METABOLITE; INDOLE DERIVATIVE; LIPID; LIPOSOME; ORGANOMETALLIC COMPOUND; ZN(II)-PHTHALOCYANINE;

ANIMAL CELL; ARTICLE; CANCER CELL LINE; CELL DEATH; CELL MEMBRANE; CELL STRUCTURE; CELLULAR DISTRIBUTION; IN VITRO STUDY; IRRADIATION; LIPOSOMAL DELIVERY; MEMBRANE DAMAGE; MEMBRANE FUSOGENIC LIPOSOME; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SYNTHESIS; TARGET CELL; ANIMAL; CELL SURVIVAL; CHEMICAL PHENOMENA; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; HUMAN; MEDICINAL CHEMISTRY; MEMBRANE FUSION; METABOLISM; NECROSIS; NEOPLASM; PATHOLOGY; PHARMACEUTICS; PHOTOCHEMOTHERAPY; PROCEDURES; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INDOLES; LIPIDS; LIPOSOMES; MEMBRANE FUSION; MICE; NECROSIS; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; TECHNOLOGY, PHARMACEUTICAL;

EID: 84906948225     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.05.049     Document Type: Article

References (41)

1. A. Urruticoechea, R. Alemany, J. Balart, A. Villanueva, F. Vinals, G. Capella, Recent advances in cancer therapy: An overview, Curr. Pharm. Des. 16 (2010) 3-10.
2. S.B. Brown, E.A. Brown, I.Walker, The present and future role of photodynamic therapy in cancer treatment, Lancet Oncol. 5 (2004) 497-508.
3. T.J. Dougherty, C.J. Gomer, G. Jori, D. Kessel, M. Korbelik, J. Moan, et al., Photodynamic therapy, J. Natl. Cancer Inst. 90 (1998) 889-905.
4. P. Agostinis, K. Berg, K.A. Cengel, T.H. Foster, A.W. Girotti, S.O. Gollnick, et al., Photodynamic therapy of cancer: An update, CA Cancer J. Clin. 61 (2011) 250-281.
5. Z. Huang, A review of progress in clinical photodynamic therapy, Technol. Cancer Res. Treat. 4 (2005) 283.
6. L.E. Rhodes, M. de Rie, Y. Enström, et al., Photodynamic therapy using topical methyl a minolevulinate vs surgery for nodular basal cell carcinoma: results of amulticenter randomized prospective trial, Arch. Dermatol. 140 (2004) 17-23.
7. D.E. Dolmans, D. Fukumura, R.K. Jain, Photodynamic therapy for cancer, Nat. Rev. Cancer 3 (2003) 380-387.
8. D. Kessel, Subcellular localization of photosensitizing agents: introduction, Photochem. Photobiol. 65 (1997) 387-388.
9. A.P. Castano, T.N. Demidova, M.R. Hamblin, Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization, Photodiagn. Photodyn. Ther. 1 (2004) 279-293.
10. C. Fabris, G. Valduga, G. Miotto, L. Borsetto, G. Jori, S. Garbisa, et al., Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis, Cancer Res. 61 (2001) 7495-7500.
11. Z. Malik, I. Amit, C. Rothmann, Subcellular localization of sulfonated tetraphenyl porphines in colon carcinoma cells by spectrally resolved imaging, Photochem. Photobiol. 65 (1997) 389-396.
12. C. Yow, J. Chen, N. Mak, N. Cheung, A. Leung, Cellular uptake, subcellular localization and photodamaging effect of temoporfin (mTHPC) in nasopharyngeal carcinoma cells: comparison with hematoporphyrin derivative, Cancer Lett. 157 (2000) 123-131.
13. A.A. Rosenkranz, D.A. Jans, A.S. Sobolev, Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency, Immunol. Cell Biol. 78 (2000) 452-464.
14. A.A. Rosenkranz, V.G. Lunin, O.V. Sergienko, D.G. Gilyazova, O.L. Voronina, D.E. Jans, et al., Targeted intracellular site-specific drug delivery: photosensitizer targeting to melanoma cell nuclei, Russ. J. Genet. 39 (2003) 198-206.
15. Y.N. Konan, J. Chevallier, R. Gurny, E. Allémann, Encapsulation of p-THPP into nanoparticles: cellular uptake, subcellular localization and effect of serum on photodynamic activity, Photochem. Photobiol. 77 (2003) 638-644.
16. D.K. Chatterjee, L.S. Fong, Y. Zhang, Nanoparticles in photodynamic therapy: An emerging paradigm, Adv. Drug Deliv. Rev. 60 (2008) 1627-1637.
17. M. Zhang, T. Murakami, K. Ajima, K. Tsuchida, A.S.D. Sandanayaka, O. Ito, et al., Fabrication of ZnPc/protein nanohorns for double photodynamic and hyperthermic cancer phototherapy, Proc. Natl. Acad. Sci. 105 (2008) 14773-14778.
18. R. Allison, H. Mota, V. Bagnato, C. Sibata, Bio-nanotechnology and photodynamic therapy-state of the art review, Photodiagn. Photodyn. Ther. 5 (2008) 19-28.
19. M. Fadel, K. Kassab, D.A. Fadeel, Zinc phthalocyanine-loaded PLGA biodegradable nanoparticles for photodynamic therapy in tumor-bearing mice, Lasers Med. Sci. 25 (2010) 283-292.
20. T. Nann, Nanoparticles in photodynamic therapy, Nano Biomed. Eng. 3 (2011).
21. . J. Lee, H. Koo, D.-E. Lee, S. Min, S. Lee, X. Chen, et al., Tumor-homing photo sensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system, Biomaterials 32 (2011) 4021-4029.
22. L. Li, Z. Luo, Z. Chen, J. Chen, S. Zhou, P. Xu, et al., Enhanced photodynamic efficacy of zinc phthalocyanine by conjugating to heptalysine, Bioconjug. Chem. 23 (2012) 2168-2172.
23. J. Lin, S.Wang, P. Huang, Z.Wang, S. Chen, G. Niu, et al., Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapy, ACS Nano 7 (2013) 5320-5329.
24. A.S.L. Derycke, P.A.M. de Witte, Liposomes for photodynamic therapy, Adv. Drug Deliv. Rev. 56 (2004) 17-30.
25. C.S. Jin, G. Zheng, Liposomal nanostructures for photo sensitizer delivery, Lasers Surg. Med. 43 (2011) 734-748.
26. M. S. Muthu, S.-S. Feng, Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success, Expert Opin. Drug Deliv. 10 (2013) 151-155.
27. E. Reddi, C. Zhou, R. Biolo, E. Menegaldo, G. Jori, Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency, Br. J. Cancer 61 (1990) 407-411.
28. A.M. Garcia, E. Alarcon, M. Munoz, J.C. Scaiano, A.M. Edwards, E. Lissi, Photophysical behaviour and photodynamic activity of zinc phthalocyanines associated to liposomes, Photochem. Photobiol. Sci. 10 (2011) 507-514.
29. V.P. Torchilin, Recent advances with lipo somes as pharmaceutical carriers, Nat. Rev. Drug Discov. 4 (2005) 145-160.
30. Y.-J. Hsieh, C.-C. Wu, C.-J. Chang, J.-S. Yu, Subcellular localization of Photofrin(r) determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets, J. Cell. Physiol. 194 (2003) 363-375.
31. N. Cauchon, M. Nader, G. Bkaily, J. E. Lier, D. Hunting, Photodynamic activity of substituted zinc trisulfophthalocyanines: role of plasma membrane damage, Photochem. Photobiol. 82 (2006) 1712-1720.
32. M. Mitsunaga, M. Ogawa, N. Kosaka, L.T. Rosenblum, P.L. Choyke, H. Kobayashi, Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules, Nat. Med. 17 (2011) 1685-1691.
33. M.E. Bulina, D.M. Chudakov, O.V. Britanova, Y.G. Yanushevich, D.B. Staroverov, T.V. Chepurnykh, et al., A genetically encoded photosensitizer, Nat. Biotechnol. 24 (2006) 95-99.
34. M.N. Sibata, A.C. Tedesco, J.M.Marchetti, Photophysicals and photochemicals studies of zinc(II) phthalocyanine in long time circulation micelles for photodynamic therapy use, Eur. J. Pharm. Sci. 23 (2004) 131-138.
35. G. Gopalakrishnan, C. Danelon, P. Izewska, M. Prummer, P.-Y. Bolinger, I. Geissbühler, et al., Multifunctional lipid/quantum dot hybrid nanocontainers for controlled targeting of live cells, Angew. Chem. Int. Ed. 45 (2006) 5478-5483.
36. S. Krasnici, A.Werner, M.E. Eichhorn, M. Schmitt-Sody, S.A. Pahernik, B. Sauer, et al., Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels, Int. J. Cancer 105 (2003) 561-567.
37. C.R. Miller, B. Bondurant, S.D. McLean, K.A. McGovern, D.F. O'Brien, Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and end ocytosis of conventional and sterically stabilized liposomes, Biochemistry 37 (1998) 12875-12883.
38. R.R. Perry, W. Matthews, J.B. Mitchell, A. Russo, S. Evans, H.I. Pass, Sensitivity of different human lung cancer histologies to photodynamic therapy, Cancer Res. 50 (1990) 4272-4276.
39. V.L. Johnson, S.C. Ko, T.H. Holmstrom, J.E. Eriksson, S.C. Chow, Effector caspases are dispensable for the early nuclear morphological changes during chemical-induced apoptosis, J. Cell Sci. 113 (2000) 2941-2953.
40. S. A. Susin, E. Daugas, L. Ravagnan, K. Samejima, N. Zamzami, M. Loeffler, et al., Two distinct pathways leading to nuclear apoptosis, J. Exp. Med. 192 (2000) 571-580.
41. W.P. Thorpe, M. Toner, R.M. Ezzell, R.G. Tompkins, M.L. Yarmush, Dynamics of photoinduced cell plasma membrane injury, Biophys. J. 68 (1995) 2198-2206.